BR9609882A - Vacina processos para preparar a mesma para tratar uma doença infecciosa para inserir uma molécula de ácido nucleico em uma célula de marcaç o para administrar um agente terapêutico a um hospedeiro e para triar um antígeno imunogênico de um patógeno uso de uma vesícula de membrana composição farmacêutica sistema de liberação de drogas e vesícula de membrana - Google Patents
Vacina processos para preparar a mesma para tratar uma doença infecciosa para inserir uma molécula de ácido nucleico em uma célula de marcaç o para administrar um agente terapêutico a um hospedeiro e para triar um antígeno imunogênico de um patógeno uso de uma vesícula de membrana composição farmacêutica sistema de liberação de drogas e vesícula de membranaInfo
- Publication number
- BR9609882A BR9609882A BR9609882A BR9609882A BR9609882A BR 9609882 A BR9609882 A BR 9609882A BR 9609882 A BR9609882 A BR 9609882A BR 9609882 A BR9609882 A BR 9609882A BR 9609882 A BR9609882 A BR 9609882A
- Authority
- BR
- Brazil
- Prior art keywords
- membrane vesicle
- pathogen
- administer
- treat
- host
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 239000012528 membrane Substances 0.000 title 2
- 208000035473 Communicable disease Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 238000002372 labelling Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 230000001717 pathogenic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6006—Cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US190395P | 1995-08-04 | 1995-08-04 | |
PCT/CA1996/000526 WO1997005899A2 (en) | 1995-08-04 | 1996-08-02 | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9609882A true BR9609882A (pt) | 1999-07-27 |
Family
ID=21698360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9609882A BR9609882A (pt) | 1995-08-04 | 1996-08-02 | Vacina processos para preparar a mesma para tratar uma doença infecciosa para inserir uma molécula de ácido nucleico em uma célula de marcaç o para administrar um agente terapêutico a um hospedeiro e para triar um antígeno imunogênico de um patógeno uso de uma vesícula de membrana composição farmacêutica sistema de liberação de drogas e vesícula de membrana |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0841944A2 (pt) |
AU (1) | AU707131B2 (pt) |
BR (1) | BR9609882A (pt) |
CA (1) | CA2182637A1 (pt) |
WO (1) | WO1997005899A2 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
GB0103171D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
GB0130123D0 (en) | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
AU2003225432A1 (en) * | 2002-04-04 | 2003-10-20 | Applied Nanosystems B.V. | Delivery of a substance to a pre-determined site |
EP1350507A1 (en) * | 2002-04-04 | 2003-10-08 | Applied NanoSystems B.V. | Delivery of a substance to a pre-determinated site |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
FR2859218A1 (fr) * | 2003-08-25 | 2005-03-04 | Centre Nat Rech Scient | Microvesicules de membrane externe marquees, leur procede de production et leurs utilisations |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
WO2009130649A2 (en) * | 2008-04-21 | 2009-10-29 | Nanoxis Ab | Plasma membrane vesicles and methods of making and using same |
WO2011027956A2 (ko) | 2009-09-04 | 2011-03-10 | 주식회사이언메딕스 | 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델 |
WO2011027971A2 (ko) | 2009-09-01 | 2011-03-10 | 주식회사이언메딕스 | 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법 |
CA2815275C (en) * | 2010-10-27 | 2023-09-19 | Glaxosmithkline Biologicals S.A. | Immunogenic compositions derived from shigella |
CA2929126C (en) | 2013-11-13 | 2020-01-07 | University Of Oslo | Outer membrane vesicles and uses thereof |
CN112402601B (zh) * | 2019-08-22 | 2022-09-13 | 四川大学 | 金黄色葡萄球菌膜囊泡及其制备方法与应用 |
CN112410240B (zh) * | 2019-08-22 | 2022-10-18 | 四川大学 | 铜绿假单胞菌膜囊泡及其制备方法与应用 |
CN114364396B (zh) * | 2019-08-22 | 2024-01-23 | 四川大学 | 铜绿假单胞菌疫苗在抗烧烫伤感染中的应用 |
US20220378902A1 (en) * | 2019-08-22 | 2022-12-01 | Sichuan University | Bacterial membrane vesicles, and separation and preparation system and method therefor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE120093T1 (de) * | 1988-12-19 | 1995-04-15 | Praxis Biolog Inc | Meningococcales klasse i-aussenmembranprotein- vakzin. |
AU7239191A (en) * | 1990-01-25 | 1991-08-21 | University Of Colorado Foundation, Inc., The | Method for preventing immune suppression in trauma patients |
SU1708351A1 (ru) * | 1990-02-05 | 1992-01-30 | Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи | Штамм бактерий SнIGеLLа SoNNeI используемый дл приготовлени живой вакцины против дизентерии Зонне |
NL9002092A (nl) * | 1990-09-25 | 1992-04-16 | Nederlanden Staat | Vaccin, geschikt voor de bestrijding van bordetella pertussis. |
ES2083343T3 (es) * | 1992-04-10 | 1997-12-01 | Schweiz Serum & Impfinst | Vacunas recombinantes vivas contra patogenos entericos gram negativos. |
WO1993022423A1 (en) * | 1992-04-29 | 1993-11-11 | Microcarb Inc. | Nutrient phospholipids for pathogenic bacteria |
AU5014393A (en) * | 1992-08-13 | 1994-03-15 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | The use of cd4 plasma membrane vesicles (pmv) as a therapeutic agent for aids |
NL9201716A (nl) * | 1992-10-02 | 1994-05-02 | Nederlanden Staat | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
-
1996
- 1996-08-02 BR BR9609882A patent/BR9609882A/pt not_active Application Discontinuation
- 1996-08-02 CA CA002182637A patent/CA2182637A1/en not_active Abandoned
- 1996-08-02 EP EP96925628A patent/EP0841944A2/en not_active Withdrawn
- 1996-08-02 AU AU66095/96A patent/AU707131B2/en not_active Ceased
- 1996-08-02 WO PCT/CA1996/000526 patent/WO1997005899A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2182637A1 (en) | 1997-02-05 |
AU707131B2 (en) | 1999-07-01 |
EP0841944A2 (en) | 1998-05-20 |
WO1997005899A2 (en) | 1997-02-20 |
WO1997005899A3 (en) | 1997-05-29 |
AU6609596A (en) | 1997-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9609882A (pt) | Vacina processos para preparar a mesma para tratar uma doença infecciosa para inserir uma molécula de ácido nucleico em uma célula de marcaç o para administrar um agente terapêutico a um hospedeiro e para triar um antígeno imunogênico de um patógeno uso de uma vesícula de membrana composição farmacêutica sistema de liberação de drogas e vesícula de membrana | |
McCluskie et al. | Cutting edge: CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice | |
Webster et al. | Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin | |
AU749282B2 (en) | Immunostimulant emulsion | |
Pupo et al. | Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization–extrusion technique | |
US4455142A (en) | Method of coadministering an antigen and an immunopotentiator | |
BR9911163A (pt) | Formulação de vacina, formulação farmacêutica, vìrus atenuado de influenza, processos para vacinar um indivìduo, para prevenir uma doença infecciosa em um indivìduo, e, para tratar ou prevenir tumores em um indivìduo | |
BR0014281A (pt) | Vacina contra vìrus de gripe intranasal | |
PT815235E (pt) | Vacinas para peste | |
BRPI0010612B8 (pt) | vacinas | |
DE68921389D1 (de) | Influenzaimpfstoff und Adjuvanten. | |
NO20032438L (no) | Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene | |
PT90731A (pt) | Processo para a preparacao de uma molecula de adn recombinante, de vacina para proteccao contra hiv e de diagnostico de exposicao a hiv | |
BR9712518A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico | |
SE9703191L (sv) | Läkemedel för förbättring av muskelfunktionsdurationen eller behandling av muskelstörningar eller -sjukdom | |
BR9815255A (pt) | Toxina de botulismo modificada, vacina oralcontra o botulismo, vacina oral contra umantìgeno selecionado e método para ministraroralmente um agente terapêutico a um animal | |
AR012376A1 (es) | Formulacion de gel para la aplicacion topica | |
DE69533128D1 (de) | Pharmazeutische akzeptabel dnase zusammensetzung | |
FR2737721B1 (fr) | Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant | |
SE9704401D0 (sv) | Matrix pellets for greasy, oily or sticky drug substances | |
PT1165081E (pt) | Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral | |
Jones et al. | Protollin™: a novel adjuvant for intranasal vaccines | |
FR2757169B1 (fr) | Proteine de fusion comportant tout ou partie de la proteine pp65 de cmv humain, utile notamment dans la preparation d'un vaccin | |
KR101136107B1 (ko) | 알킬포스파티딜콜린과 혼합된 백신 조성물 | |
ATE246491T1 (de) | Impfstoffzusammensetzung auf basis von partikeln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |